EZH2 and diffuse large B-cell lymphoma: McCabe et al. showed that GSK126 effectively inhibited the proliferation of EZH2 mutant diffuse large B cell lymphoma (DLBCL) cell lines and markedly inhibits the growth of EZH2 mutant DLBCL xenografts in mice.